PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAG9. A total of 2 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $32,000 | -11.1% | 30,000 | -11.8% | 0.00% | – |
| Q1 2020 | $36,000 | -2.7% | 34,000 | 0.0% | 0.00% | – |
| Q4 2019 | $37,000 | 0.0% | 34,000 | -12.8% | 0.00% | – |
| Q3 2019 | $37,000 | -33.9% | 39,000 | -26.4% | 0.00% | – |
| Q2 2019 | $56,000 | +24.4% | 53,000 | +35.9% | 0.00% | – |
| Q1 2019 | $45,000 | +15.4% | 39,000 | 0.0% | 0.00% | – |
| Q4 2018 | $39,000 | – | 39,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 8,575,000 | $7,002,000 | 7.67% |
| Man Investments (CH) AG | 4,500,000 | $3,645,000 | 2.12% |
| Park West Asset Management LLC | 22,250,000 | $17,870,000 | 1.38% |
| Telemetry Investments, L.L.C. | 3,000,000 | $2,409,000 | 1.36% |
| WHITEBOX ADVISORS LLC | 27,961,000 | $22,456,000 | 0.89% |
| Kissinger Financial Services LLC | 2,652,000 | $2,127,000 | 0.74% |
| ZAZOVE ASSOCIATES LLC | 9,560,000 | $7,839,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,700,000 | $13,528,000 | 0.18% |
| LINDEN ADVISORS LP | 4,000,000 | $3,253,000 | 0.13% |
| AQR Arbitrage LLC | 5,000,000 | $4,041,000 | 0.04% |